Algenis
21 September 2018
Algenis specializes in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases.
You may be interested in...
-
SoftBank Member Profile; Canary and Valor Capital Each Raise USD100m
-
LAVCA Q1 Data Sneak Peek; Kavak, Merama Updates; Igah Raises Fresh Capital
-
Lafise Deal Case; Advent, SoftBank and Valor Invest in Mexico and Brazil’s Merama
-
Patria Invests ~USD54.5m in Brazil’s Randoncorp
Patria Investments invested BRL320m (~USD54.5m) in Randoncorp, a Brazil-based holding...